Skip to main content
Premium Trial:

Request an Annual Quote

Biofidelity: Robert Osborne

Biofidelity has appointed Robert Osborne as its chief operating officer. Osborne previously served as senior VP of technology and assay development at Inivata. Prior to Inivata, Osborne served as principal staff scientist at the Wellcome Trust Sanger Institute, director of technology development at its spinout company, 14M Genomics, and director of research at Population Genetics Technologies.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.